Cargando…

Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.

BACKGROUND: Hydroxychloroquine (HCQ) is an anti-malarial and immunomodulatory drug considered a potential candidate for drug repurposing in COVID-19 due to their in vitro antiviral activity against SARS-CoV-2. Despite the potential antiviral effects and anti-inflammatory profile, the results based o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martins-Filho, Paulo Ricardo, Ferreira, Lis Campos, Heimfarth, Luana, Araújo, Adriano Antunes de Souza, Quintans-Júnior, Lucindo José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403035/ https://www.ncbi.nlm.nih.gov/pubmed/34485970 http://dx.doi.org/10.1016/j.lana.2021.100062

Ejemplares similares

Ivermectin: Panacea or true promise for COVID-19
por: Heimfarth, Luana, et al.
Publicado: (2020)

Drug repurposing and cytokine management in response to COVID-19: A review
por: Heimfarth, Luana, et al.
Publicado: (2020)

Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity
por: Rocha Santos Passos, Fabiolla, et al.
Publicado: (2022)

Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives
por: da Silva, Manuele Figueiredo, et al.
Publicado: (2022)

Insights into the actions of angiotensin-1 receptor (AT1R) inverse agonists: Perspectives and implications in COVID-19 treatment
por: Heimfarth, Luana, et al.
Publicado: (2021)

ChatGPT: the new panacea of the academic world
por: Quintans-Júnior, Lucindo José, et al.
Publicado: (2023)

The Pandora's box of predatory journals
por: Quintans-Júnior, Lucindo J., et al.
Publicado: (2023)

Racial Disparities in COVID-19-related Deaths in Brazil: Black Lives Matter?
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2021)

Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
por: Grau-Pujol, Berta, et al.
Publicado: (2021)

Dynamics of hospitalizations and in-hospital deaths from COVID-19 in northeast Brazil: a retrospective analysis based on the circulation of SARS-CoV-2 variants and vaccination coverage
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Cyclodextrin–Drug Inclusion Complexes: In Vivo and In Vitro Approaches
por: Carneiro, Simone Braga, et al.
Publicado: (2019)

COVID-19 Mortality and Case-Fatality Rates in Sergipe State, Northeast Brazil, From April to June 2020
por: Martins-Filho, Paulo R., et al.
Publicado: (2021)

The Rising Significance of Soft Skills in Postgraduate Education: Nurturing Well-Rounded Professionals for the Modern World
por: Quintans-Júnior, Lucindo José, et al.
Publicado: (2023)

Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Miller Fisher Syndrome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2021)

Factors Associated with Mortality among Hospitalized Patients with COVID-19: A Retrospective Cohort Study
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2021)

Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers
por: Polo, Rosa, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

A Systematic Review for Anti-Inflammatory Property of Clusiaceae Family: A Preclinical Approach
por: de Melo, Mônica Santos, et al.
Publicado: (2014)

Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)
por: Naggie, Susanna, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study
por: de Souza Araújo, Adriano Antunes, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in low-income university students
por: Araújo, Adriano Antunes de Souza, et al.
Publicado: (2021)

Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
por: Kaur, Hardeep, et al.
Publicado: (2021)

Kinetics of humoral immune response in patients with asymptomatic or mild COVID-19: a longitudinal study based in an in-house indirect ELISA method
por: de Lima Silva, Nathanielly, et al.
Publicado: (2022)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 infection among urban cleaning and solid waste management workers during transmission of the Omicron variant in Brazil
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2023)

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial
por: Abella, Benjamin S., et al.
Publicado: (2020)

Risks of hydroxychloroquine use for COVID-19 prophylaxis
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
por: Dubée, Vincent, et al.
Publicado: (2021)

COVID-19: Hydroxychloroquine prophylaxis is just a prophylaxis! Be careful and perceive it right
por: Garg, Rakesh, et al.
Publicado: (2022)

Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis
por: Stricker, Raphael B., et al.
Publicado: (2021)

Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism
por: Perrella, Alessandro, et al.
Publicado: (2021)

Hydroxychloroquine pre-exposure prophylaxis for COVID-19 among healthcare workers: Initial experience from India
por: Kadnur, Harshith B., et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”
por: Grant-Kels, Jane M.
Publicado: (2020)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
por: Faruqui, Atiya R., et al.
Publicado: (2021)

New prophylaxis regimen for SARS-CoV-2 infection in health professionals with low doses of hydroxychloroquine and bromhexine: a randomised, double-blind placebo clinical trial (ELEVATE Trial)
por: Granados-Montiel, Julio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8k7ss9quseogqhuvpfbgn6u8jf